Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Research & Development: 2024-2025

Historic Research & Development for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $17.8 million.

  • Pyxis Oncology's Research & Development rose 0.38% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year change of. This contributed to the annual value of $58.7 million for FY2024, which is 18.47% up from last year.
  • Latest data reveals that Pyxis Oncology reported Research & Development of $17.8 million as of Q3 2025, which was up 3.94% from $17.1 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Research & Development ranged from a high of $17.8 million in Q3 2025 and a low of $13.0 million during Q1 2024.
  • Its 2-year average for Research & Development is $15.8 million, with a median of $17.0 million in 2025.
  • Data for Pyxis Oncology's Research & Development shows a peak YoY surged of 30.82% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Research & Development stood at $14.0 million in 2024, then increased by 0.38% to $17.8 million in 2025.
  • Its Research & Development stands at $17.8 million for Q3 2025, versus $17.1 million for Q2 2025 and $17.0 million for Q1 2025.